
IBEX TECHNOLOGIES INC. — Investor Relations & Filings
IBEX Technologies Inc. develops, manufactures, and markets high-purity enzymes and specialized reagents for biomedical use. The company's product portfolio includes a family of proprietary enzymes utilized in pharmaceutical research, notably for applications in arthritis and oncology, and diagnostic products. IBEX serves the In Vitro Diagnostics (IVD) sector and general research markets by supplying essential raw materials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Decision Document / Order for Application - French.pdf | 2024-05-24 | English | |
| Material change report - English.pdf | 2024-04-08 | English | |
| News release - English.pdf | 2024-04-08 | English | |
| News release - English.pdf | 2024-04-08 | English | |
| Material change report - English.pdf | 2024-04-03 | English | |
| News release - English.pdf | 2024-04-03 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 30148826 | Decision Document / Order for Application - French.pdf | 2024-05-24 | English | ||
| 29760856 | Material change report - English.pdf | 2024-04-08 | English | ||
| 29760993 | News release - English.pdf | 2024-04-08 | English | ||
| 29760953 | News release - English.pdf | 2024-04-08 | English | ||
| 13730488 | Material change report - English.pdf | 2024-04-03 | English | ||
| 13730501 | News release - English.pdf | 2024-04-03 | English | ||
| 13727927 | Material document(s).pdf | 2024-03-14 | English | ||
| 13727926 | Material document(s).pdf | 2024-03-14 | English | ||
| 13727924 | Material document(s).pdf | 2024-03-14 | English | ||
| 13728244 | News release - English.pdf | 2024-03-14 | English | ||
| 13726819 | Management information circular (amended) - English.pdf | 2024-03-13 | English | ||
| 13721729 | News release - English.pdf | 2024-02-23 | English | ||
| 13721825 | Form of proxy - English.pdf | 2024-02-23 | English | ||
| 13721823 | Other.pdf | 2024-02-23 | English | ||
| 13721822 | Other.pdf | 2024-02-23 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Harmony Biosciences Holdings, Inc.
Develops and commercializes therapies for rare neurological…
|
HRMY | US | Manufacturing |
|
HARROW, INC.
An eyecare pharmaceutical company that develops and commerc…
|
HROW | US | Manufacturing |
|
HAVN Life Sciences Inc.
Standardized extraction and formulation of psychoactive com…
|
HAVN | CA | Manufacturing |
|
HBM Holdings Limited
Biopharmaceutical company developing novel antibody therape…
|
2142 | KY | Manufacturing |
|
HCW Biologics Inc.
Develops immunotherapies for diseases linked to aging and c…
|
HCWB | US | Manufacturing |
|
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Specializes in the production of heparin-based APIs and ant…
|
300255 | CN | Manufacturing |
|
Hefei Lifeon Pharmaceutical Co., Ltd.
Develops and manufactures cardiovascular, anti-infective, a…
|
003020 | CN | Manufacturing |
|
Heidelberg Pharma AG
Clinical-stage biopharma developing Amanitin-based ADCs for…
|
HPHA | DE | Manufacturing |
|
Heilongjiang ZBD Pharmaceutical Co.,Ltd.
Develops TCM, chemical and biological drugs for cardiovascu…
|
603567 | CN | Manufacturing |
|
Helix BioPharma Corp.
Clinical-stage immune-oncology firm developing bio-conjugat…
|
HBP | CA | Manufacturing |
IBEX TECHNOLOGIES INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/42661/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=42661 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=42661 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=42661 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 42661}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IBEX TECHNOLOGIES INC. (id: 42661)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.